| Application no. and date | 14171253.9 (espacenet) (Federated) (European Patent Register), 20101202 | | Patent/reg. no. and date | DK/EP 2774595, 20170419 | | Publication date | 20140910 | | Priority no. and date | US 266103 P, 20091202 | | EP pub. no. and date |
EP 2774595 20140910 | | Effective date | | | Applicant/owner | Otsuka Pharmaceutical Co., Ltd., 2-9, Kanda Tsukasa-machi
Chiyoda-ku
Tokyo 101-8535, JP | | Applicant ref. no. | P167257.DK.01/HUTCHESONM | | Inventor | HAFEZI, Hooman, 64 Eddystone Court
Redwood City, CA 94065, US,
ROBERTSON, Timothy, 2719 Sequoia Way
Belmont, CA 94002, US,
Costello, Benedict, 218 San Carlos Avenue
Piedmont, CA 94611, US,
Duck, Robert, 1800 Washington Street, 118
San Francisco, CA 94106, US | | Representative | MURGITROYD & COMPANY, Mannerheimvägen 12B, 5tr
FI-00100 Helsingfors, FI | | Opponent | | | IPC Class | A61J 3/06 (2006.01) , A61J 3/10 (2006.01) , A61K 9/20 (2006.01) , A61K 9/48 (2006.01) , A61M 31/00 (2006.01) | | Title | Integreret indtageligt hændelsesmarkørsystem med farmaceutisk produkt | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
